The expression of CBRs in the placenta shows promise as a reliable marker of the risk of PTB. This highlights the significance of the ECS in pregnancy and childbirth. Our findings contribute to the growing body of research on prenatal biomarkers, introducing a possible new area of study that has the potential to enhance prenatal diagnosis and therapies. Therefore, further studies are needed to assess the expression of the CBR during pregnancy.
References